A Chizuka
Overview
Explore the profile of A Chizuka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chizuka A, Suda M, Shibata T, Kusumi E, Hori A, Hamaki T, et al.
Leukemia
. 2006 Oct;
20(10):1655-7.
PMID: 17041635
No abstract available.
2.
Fujisaki G, Kami M, Murashige N, Kishi Y, Hori A, Chizuka A, et al.
Bone Marrow Transplant
. 2006 Jan;
37(6):617-9.
PMID: 16444281
No abstract available.
3.
Chizuka A, Kami M, Kanda Y, Murashige N, Kishi Y, Hamaki T, et al.
Bone Marrow Transplant
. 2005 Jan;
35(6):577-82.
PMID: 15665840
Bloodstream infection (BSI) is a significant complication following allogeneic hematopoietic stem cell transplantation (allo-SCT). Corticosteroids mask inflammatory responses, delaying the initiation of antibiotics. We reviewed medical records of 69 allo-SCT...
4.
Maeda T, Kusumi E, Kami M, Kawabata M, Le Pavoux A, Hara S, et al.
Bone Marrow Transplant
. 2004 Nov;
35(1):91-7.
PMID: 15516933
Allogeneic hematopoietic stem cell transplantation (allo-SCT) recipients are prone to infections. The incidences of mycobacterial infections after allo-SCT in several case series vary from less than 0.1-5.5%. However, no study...
5.
Nakai K, Kanda Y, Mineishi S, Hori A, Chizuka A, Niiya H, et al.
Ann Hematol
. 2002 Nov;
81(10):593-6.
PMID: 12424542
A 19-year-old woman with myelodysplastic syndrome underwent reduced-intensity stem cell transplantation [RIST: (cladribine 0.11 mg/kg for 6 days, busulfan 4 mg/kg for 2 days, and rabbit antithymocyte globulin)] from her...
6.
Nakai K, Kanda Y, Mineishi S, Saito T, Ohnishi M, Niiya H, et al.
Bone Marrow Transplant
. 2002 Feb;
29(3):237-41.
PMID: 11859396
A reduced-intensity hematopoietic stem cell transplantation (RIST) regimen was developed to induce immunosuppression to facilitate the engraftment of donor cells. However, there have been concerns that the incidence of opportunistic...
7.
Chizuka A, Kanda Y, Nannya Y, Oshima K, Kaneko M, Yamamoto R, et al.
Clin Lab Haematol
. 2002 Feb;
24(1):33-6.
PMID: 11843896
Flow cytometry (FC) is widely utilized in the diagnosis of lymphoma and the light chain ratio (LCR) is especially useful in the diagnosis of B-cell malignancy. In this study we...
8.
Kaneko M, Kanda Y, Oshima K, Nannya Y, Suguro M, Yamamoto R, et al.
Ann Hematol
. 2002 Jan;
81(1):33-6.
PMID: 11807633
The range of survival duration in myeloma patients is wide and several percent of patients live longer than 10 years. Therefore, a precise prediction of survival for the individual patient...
9.
Kanda Y, Mineishi S, Saito T, Saito A, Yamada S, Ohnishi M, et al.
Bone Marrow Transplant
. 2001 Nov;
28(7):689-92.
PMID: 11704792
To evaluate the efficacy of long-term administration of acyclovir as prophylaxis against varicella-zoster virus (VZV) reactivation, we analyzed the medical records of 86 consecutive adult patients who obtained engraftment after...
10.
Niiya H, Kanda Y, Saito T, Ohnishi T, Kanai S, Kawano Y, et al.
Haematologica
. 2001 Oct;
86(10):1071-4.
PMID: 11602413
Background And Objectives: The aim of this study was to evaluate lineage-specific chimerism reconstitution after reduced-intensity allogeneic stem cell transplantation (RIST) using a combination of fludarabine (30 mg/m2 for 6...